HOME › DRUGS › TROFINETIDE
ACTIVE SUBSTANCE / INN

TROFINETIDE

Brand name(s): DAYBUE STIX, Daybu, DAYBUE
FDA LISTED
EMA LISTED
PRESCRIPTION
OPINION UNDER RE-EXAMINATION
NDA219884
NDA217026
ACTIVE SUBSTANCE
Trofinetide
REGULATORS
FDA · EMA
SPONSORS / MAH
ACADIA PHARMS INC, Acadia Pharmaceuticals B.V.
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DAYBUE STIXNDA219884ACADIA PHARMS INCPrescription
DAYBUENDA217026ACADIA PHARMS INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DaybuAcadia Pharmaceuticals B.V.Opinion under re-examinationRett Syndrome

FULL INTELLIGENCE ON TROFINETIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →